| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.9 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |